Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...

Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost ...

In our gastrointestinal disease focus month, we speak with FDA spokesperson, Lisa Kubaska on how the FDA reaches decisions on treatments in this area. The role of the Gastrointestinal Drugs ...

The TB Drug Accelerator, a partnership of seven pharmaceutical companies and four research institutions, has been launched with the aim to speed discovery of essential new treatments for ...

The intense campaign of airstrikes in Yemen under Donald Trump, targeting the rebels over their attacks on shipping in Mideast waters stemming from the Israel-Hamas war, has killed 67 people ...